- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CA:TLRY
Recent news which mentions CA:TLRY
Molson Coors sheds no tears as Tilray buys its remaining 58% stake in THC drink company Truss Beverage
August 18, 2023
From MarketWatch
Once-mighty Canopy Growth loses billions as dream of pot riches runs into reality of oversupply and overspending
July 14, 2023
From MarketWatch
Analyst cuts Canopy Growth’s price target to $0
July 05, 2023
From MarketWatch
From MarketWatch
From MarketWatch
Left for dead, the once-popular 60/40 investment strategy is about to make a comeback
April 11, 2023
From MarketWatch
Norway’s sovereign fund will shun Canadian cannabis companies because the substance is still illegal in that country
September 08, 2022
From MarketWatch
Akanda pivots to German market as cannabis reform gains traction
August 30, 2022
From MarketWatch
From MarketWatch
From MarketWatch
Tilray expected to post a quarterly loss with market share losses in Canada and forex headwinds
July 27, 2022
From MarketWatch
From MarketWatch
From MarketWatch
Inflation has knocked back the market. Here are the key S&P 500 and tech stock levels one strategist fears.
February 11, 2022
From MarketWatch
From MarketWatch
Tilray expected to grow sales sequentially but remain in the red
January 06, 2022
From MarketWatch
Canada’s cannabis companies cut 6,000 jobs during COVID-19 pandemic
November 19, 2021
From MarketWatch
Tilray shares climb as investors shrug off revenue miss and bigger-than-expected loss
October 07, 2021
From MarketWatch
Canadian cannabis companies won’t turn a profit in the coming quarter and here’s why
September 24, 2021
From MarketWatch
Analysts upbeat on Tilray’s U.S. prospects after MedMen deal
August 18, 2021
From MarketWatch
Canadian cannabis companies are still not profitable almost three years into full legalization, earnings show
August 06, 2021
From MarketWatch
Tilray shares rocket 26% after it swings to a surprise profit and target of $4 billion in revenue by 2024
July 28, 2021
Tickers
TLRY
From MarketWatch
Tags
CA:TLRY
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.